Related Experiment Videos
Identification of a tumour factor inducing resistance to NK cell lysis
R Serrano1, C Alonso, R Solana
1Department of Biochemistry, Faculty of Medicine, Reina Sofía Hospital, University of Córdoba, Spain.
Abstract:
The mechanisms involved in the resistance or susceptibility of tumour cells to NK cytotoxicity are poorly understood. The role of different molecules on the target cell surface which could act as recognition elements by NK effectors has been postulated. However, there are also some tumour cell lines which release factors capable of inhibiting NK cytotoxicity. This paper presents a new factor (NK-RIF), produced and released by different tumour cell lines, making K562 resistant to NK lysis without affecting the cytotoxic function of NK effector cells. This soluble factor is shown to be thermolabile, non-dialyzable and to have a molecular weight of 36,000 daltons. It does not block the binding capacity of the target and effector cells, nor does it affect target susceptibility to LAK or cytotoxic T-cells.
Insights
Tumor cells can resist Natural Killer (NK) cell attacks due to a newly discovered factor, NK-RIF. This soluble factor makes cancer cells resistant to NK lysis without impairing NK cell function.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Cytotoxicity
Background:
- Mechanisms of tumor cell resistance to Natural Killer (NK) cell cytotoxicity are not fully understood.
- Surface molecules and inhibitory factors released by tumor cells are implicated in NK resistance.
Purpose of the Study:
- To identify and characterize novel factors involved in tumor cell resistance to NK cell-mediated lysis.
- To investigate the properties and effects of a newly discovered NK-resistance-inducing factor (NK-RIF).
Main Methods:
- Production and isolation of NK-RIF from tumor cell lines.
- Assays to evaluate NK cell cytotoxicity and binding capacity.
- Characterization of NK-RIF's physicochemical properties (thermolability, molecular weight).
Main Results:
- A novel soluble factor, NK-RIF, was identified and produced by various tumor cell lines.
- NK-RIF confers resistance to NK cell lysis on K562 cells without affecting NK effector cell function.
- NK-RIF is thermolabile, non-dialyzable, with a molecular weight of 36,000 daltons.
- NK-RIF does not inhibit target-effector cell binding or susceptibility to LAK/T-cell cytotoxicity.
Conclusions:
- NK-RIF represents a new mechanism by which tumor cells evade NK cell surveillance.
- This factor specifically induces resistance to NK cell-mediated killing, offering potential therapeutic targets.